How To Increase GABA Naturally References

How To Increase GABA Naturally References:

These references are noted on our blog article How To Increase GABA Naturally.

1. Abdou, A. M., et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 26(3):201-208, 2006.
2. Shell, W., et al. A randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleep. Am J Ther. 17(2):133-139, 2010.
3. Head, K. A., et al. Nutrients and botanicals for treatment of stress: adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep. Alternative Medicine Review. 14(2), 2009.
4. Breier, A., et al. The GABA-A/Benzodiazepine receptor: implications for the molecular basis of anxiety. Journal of Psychiatric Research. 24(Supplement 2):91-104, 1990.
5. Nemeroff, C. B., et al. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull. 37(4):133-146, 2003.
6. El Idrissi, A.. Taurine improves learning and retention in aged mice. Neurosci Lett. 2008.
7. Molchanova, S. M., et al. Effect of taurine on the concentrations of glutamate, GABA, glutamine and alanine in the rat striatum and hippocampus. Proc West Pharmacol Soc. 50:95-97, 2007.
8. Kimura R, Murata T. Influence of alkylamides of glutamic acid and related compounds on the central nervous system I. Central depressant effect of theanine. Chem Pharm Bull. 19:1257–1261, 1971.
9. Nathan, P. J., et al. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 6(2):21-30, 2006.
10. Chen, S. W., et al. Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sciences. 75(12):1503-1511, 2004.
11. Kong, W. X., et al. Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav. 2006.
12. Heese, T., et al. Anxiolytic effects of L-theanine - a component of green tea - when combined with midazolam, in the male Sprague-Dawley rat. AANA J. 77(6):445-449, 2009.
13. Ito, K., et al. Effects of L-theanine on the release of alpha brain waves in human volunteers. Nippon Nogeikagaku Kaishi. 72:153-157, 1998.
14. Lu, K., et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol. 19(7):457-465, 2004.
15. 17th European Sleep Research Society Congress. Prague. October 2004.
16. Kimura, K., et al. l-Theanine reduces psychological and physiological stress responses. Biol Psychol. 74(1):39-45, 2007.
17. Dolu, N., et al. Dose-related anxiogenic effect of glycine in the elevated plus maze and in electrodermal activity. J Basic Clin Physiol Pharmacol. 18(2):141-147, 2007.
18. Prousky, J. E. Orthomolecular treatment of anxiety disorders. Townsend Letter for Doctors and Patients. February-March 2005.
19. Nicoll, R. A. Introduction to the pharmacology of CNS drugs. In: Katzung, B. G. (editor), Basic & Clinical Pharmacology (sixth edition). Prentice-Hall International, London. 1995:323-332.
20. In-Tele-Health © 2009 (from Hyperhealth Pro CD-ROM)
21. Amsterdam, J. D., et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 29(4):378-382, 2009.
22. Viola, H., et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Medica. 61(3):213-216, 1995.
23. Yamada, K, et al. Effect of inhalation of chamomile oil vapour on plasma ACTH level in ovariectomized rats under restriction stress. Biol Pharm Bull. 19(9):1244-1246, 1996.
24. Shinomiya, K., et al. Hypnotic activities of chamomile and passiflora extracts in sleep-disturbed rats. Biol Pharm Bull. 28(5):808-810, 2005.
25. Roberts, A., et al. The effect of olfactory stimulation on fluency, vividness of imagery and associated mood: a preliminary study. Br J Med Psychol. 65(2):197-199, 1992.
26. Felter HW, Lloyd J you: King's American dispensary, ED 18, Rev 3, Portland, 1905, reprinted 1983, Eclectic Medical Publications.
27. Krenn, L. [Passion Flower (Passiflora incarnata L.) - a reliable herbal sedative.] Wien Med Wochenschr. 152(15-16):404-406, 2002.
28. Akhondzadeh, S., et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxezepam. J Clin Pharm Ther. 26(5):363-367, 2001.
29. Brown, E., et al. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J. 75(5):333-337, 2007.
30. Dhawan, K., et al. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 72(8):922-926, 2001.
31. Capasso, A., et al. Pharmacological studies on the sedative and hypnotic effect of Kava kava and Passiflora extracts combination. Phytomedicine. 12(1-2):39-45, 2005.
32. Soulimani, R., et al. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. Journal of Ethnopharmacology. 57(1):11-20, 1997.
33. Deng, S., et al. Noni as an anxiolytic and sedative: a mechanism involving its gamma-aminobutyric acidergic effects. Phytomedicine. 2007.
34. Li, Y. F., et al. Antistress effect of oligosaccharides extracted from Morinda officinalis in mice and rats. Acta Pharmacol Sin. 22(12):1084-1088, 2001.
35. Einat, H., et al. The effects of inositol treatment in animal models of psychiatric disorders. J Affect Disord. 62(1-2):113-121, 2001.
36. Barkai, A. I., et al. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psych. 13(1):65-72, 1978.
37. Benjamin, J. et al. Inositol treatment in psychiatry. Psychopharmacol Bull. 31:167-175, 1995.
38. Colodny, L., et al. Inositol - clinical applications for exogenous use. Alternative Medicine Review. 3(6):432-447, 1998.
39. Einat, H., et al. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology. 144(2):158-162, 1999.
40. Nick, G. L. Inositol as a treatment for psychiatric disorders: a scientific evaluation of its clinical effectiveness. Townsend Letter for Doctors and Patients. October 2004.
41. Head, K. A. Premenstrual syndrome: nutritional and alternative approaches. Alternative Medicine Review. 2(1):12-25, 1997.
42. Ah Kang-Yoon, S., et al. Relation of short-term pyridoxine-hydrochloride supplementation to plasma vitanin-B6 vitamers and amino acid concentrations in young women. American Journal of Clinical Nutrition. 55(4):865-872, 1992.
43. Visual textbook of nutritional medicine by Dr Igor Trabrizian ISBN 0–975 6920–5–4.
44. Grases, G., et al. Anxiety and stress among science students. Study of calcium and magnesium alterations. Magnesium Research. 19(2):102-106, 2006.
45. Hanus, M., et al. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin. 20(1):63-71, 2004.
46. Taborska, V. [Incidence of latent tetany in patients with panic disorder]. Cesk Psychiatr. 91(3):183-190, 1995.
47. Morris, M. E. Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magnesium Research. 5(4):303-313, 1992.
48. Saris, N.-E. L., et al. Magnesium: an update on physiological, clinical and analytical aspects. Clinica Chimica Acta. 294:1-26, 2000.
49. Tanabe, K., et al. Erythrocyte magnesium and prostaglandin dynamics in chronic sleep deprivation. Clin Cardiol. 20(3):265-268, 1997.
50. Webb, W. L., et al. Electrolyte and fluid imbalance: Neuropsychiatric manifestations. Psychosomatics. 22(3):199-203, 1981.
51. Jacka, F. N., et al. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 43(1):45-52, 2009.
52. Frizel, D., et al. Plasma calcium and magnesium in depression. British Journal of Psychiatry. 115(529):1375-1377, 1969.
53. Chollet, D., et al. Blood and brain magnesium in inbred mice and their correlation with sleep quality. Am J Physiol Regul Integr Comp Physiol. 279(6):R2173-R2178, 2000.
54. Poleszak, E., et al. Benzodiazepine/GABA(A) receptors are involved in magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep. 60(4):483-489, 2008.
55. Crofts, S. L., et al. Anxiety before operation and serum potassium. Anaesthesia. 45(12):1101-1102, 1990.
56. McCleane, G. J., et al. Pre-operative anxiety and serum potassium. Anaesthesia. 45(7):583-585, 1990.
57. Cox, J. R., et al. Changes in sodium, potassium and fluid spaces in depression and dementia. Gerontology Clin. 13:232-245, 1971.
58. 58. Drennan, M. D., et al. Potassium affects actigraph-identified sleep. Sleep. 14(4):357-360, 1991.
59. Weeks BS., et al formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit. 2009 Nov; 15 (11):RA256-62
60. Hoosain SJ, Aoshima H, Kiso Y. fragrances in oolong tea that enhance the response of GABA A receptors. Biosci Biotechnol Biochem. 2004 Sep;68(9): 1842 – 8.
61. Cho YR, Chang JY, Chang HC. Production of GABA byte Lactobacillus buchneri isolated from kimchi and its neuro protective effect on neuron cells J Microbiol Biotechnol. 2007 Jan;17(1):104-9
62. Inoue K, Shirai T, Ochiai H, Kassao M, Hayakawa K, Kimura M, Sansawa H. Blood pressure lowering effect of a novel fermented milk containing in mild hypertensives. J Clin Nutr. 2003 Mar; 57 (3):490-5
63. Kim JY, Lee MY, Ji GE, Lee YS, Hwang KT. Reduction of GABA black raspberry juice during fermentation by Lactobacillus brevis. Int J Food Microbiol. 2009 Mar 15;130 (1):12-6.
64. LI Y, Bai Q, Jin X, Wen H, Gu Z. Effects of cultivar and culture conditions on GABA accumulation in germinated fava beans. J Sci Food Argric. 2010 Jan 15;90(1):52-7
65. Akihiro T, Koike S, Tani R, Tominaga T, Watanabe S, Iijima Y, Aoki K, Shibata D, Ashihara H, Matsukura C, Akama K, Fujimura T, Ezura H. Biochemical mechanisms of GABA accumulation during fruit development in tomato. Plant Cell Physiol. 2008 Sept;49(9): 1378-89.
66. Kathiresan A, Tung P, Chinnappa CC, Reid DM. GABA stimulate ethylene biosynthesis in sunflower. Plant Physiol. 1997 Sept; 115 (1):129-35
67. Avallone R, Zanoli P, Corsi L, Cannazza G, Baraldi M. Benzodiazepine compounds and GABA in flower heads of matricaria chamomilla. Phytotherapy Res. 1996;10:177–179.
68. Albrecht J, Bender AS, Norenberg MD. Potassium-stimulated GABA release is a chloride-dependent but sodium- and calcium-independent process in cultured astrocytes. Acta Neurobiol Exp (Wars). 1998;58(3):169-75.
69. Wang DS, Xu TL, Li JS. 5-HTP potentiates GABA- and glycine-activated chloride currents on the same neurons in rat spinal cord. J Hirnforsch. 1999;39(4):531-7.
70. Sasaki, K., et al. Effects of chronic administration of bilobalide on amino acid levels in mouse brain. Cell Mol Biol. 48(6):681-684, 2002.
71. Houghton, P. J. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol. 51(5):505-512, 1999.
72. Ortiz, J. G., et al. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem Res. 24(11):1373-1378, 1999.
73. Trauner, G., et al. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta Medica. 74(1):19-24, 2008
74. Santos, M. S., et al. Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. Arch Int Pharmacodyn. 327(2):220-231, 1994.
75. Muller, W. E., et al. Hyperforin - antidepressant activity by a novel mechanism of action. Pharmacopsychiatry. 34(Supplement 1):S98-S102, 2001.
76. Jussofie A, Schmiz A, Hiemke C., et al. Psychopharmacology (Berl). Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. 1994 Dec;116(4):469-74.
77. Holm E, et al. Arzneimittelforschung 1991 Jul;41(7):673-683.